Australian Clinical Labs
ACL.AX
#6787
Rank
NZ$0.78 B
Marketcap
$3.90
Share price
-1.12%
Change (1 day)
38.21%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2023: $0.20

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is $0.20. In 2023 the company made an earnings per share (EPS) of $0.20 a decrease over its 2022 EPS that were of $1.04.

EPS history for Australian Clinical Labs from 2021 to 2023

Annual EPS

Year EPS Change
2023$0.20-80.55%
2022$1.04104.3%
2021$0.51